Trial Details
Not RecruitingBasic Information
| Clinical ID | c5074 |
|---|---|
| Identifier | EUCTR2018-003524-36-NL |
| Trial Title | Randomized, Multicenter Study to Investigate the Efficacy of Dashboard Driven Individualized Dosing of Infliximab Compared To Standard Dosing During the Induction in Patients with Acute Severe Ulcerative Colitis - TITRATE |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Ulcerative colitis MedDRA version: 20.1.Level: LLT.Classification code 10045365.Term: Ulcerative colitis.System Organ Class: 100000004856.;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: RemicadePharmaceutical Form: Powder for solution for infusionTrade Name: MetojectPharmaceutical Form: Trade Name: Puri-NetholPharmaceutical Form: Tablet |
Participant Information
| Sponsor | UMC Amsterdam location AMC |
|---|---|
| City | NULL |
| Country/Region | Netherlands;Norway;Ireland |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |